Prostate specific antigen in the female body: Its role in breast cancer prognosis

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 18, Issue 5, 2000, Pages 273-276

  Ulutin, H C ^a   Pak, Y ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast; Cancer; Female; Prognosis; Prostate specific antigen

Indexed keywords

BIOCHEMICAL MARKER; PROSTATE SPECIFIC ANTIGEN; TAMOXIFEN;

AMNION FLUID; ANTIGEN SPECIFICITY; BREAST CANCER; BREAST CYST; BREAST MILK; CANCER PATIENT; CYST FLUID; DRUG BLOOD LEVEL; HUMAN; MONITORING; POSTMENOPAUSE; PROGNOSIS; RECEPTOR UPREGULATION; REVIEW;

AMNIOTIC FLUID; BREAST NEOPLASMS; CYTOSOL; EXUDATES AND TRANSUDATES; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMANS; MILK, HUMAN; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; TREATMENT OUTCOME;

EID: 0033763848     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Purification of a human prostate specific antigen
2. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
3. Prostate specific antigen: Biochemistry analytical methods, and clinical application
4. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen
5. Hormonal regulation of prostate specific antigen mRNA in a human prostate adenocarcinoma line
6. Prostate-specific antigen as a marker for prostate cancer: A monoclonal and a polyclonal immunoassay compared
7. Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen
8. Time resolved immunoflometric assay of human prostate-specific antigen
9. Editorial: New biological functions of prostate-specific antigen?
10. Nonprostatic sources of prostate-specific antigen
11. Kallikrein gene expression in human pituitary tissues
12. Glandular kallikreins and prostate specific antigen are expressed in human endometrium
13. Immunocytochemical detection of prostate-specific antigen (PSA) in skin adnexal and breast tumors
14. Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues
15. Prostate-specific antigen in breast cancer, benign breast disease and normal breast tissue
16. Quantation of prostate-specific antigen immunoreactivity in human breast cyst fluids
17. Expression of the prostate-specific antigen gene by a primary ovarian carcinoma
18. False positive prostate-specific antigen values in the sera of women with renal cell carcinoma
19. A prostate-specific antigen (PSA) -like protein associated with renal cell carcinoma in women
20. Detection of prostate - Specific antigen immunoreactivity in breast tumors
21. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third generation assay: Potential applications in prostate and breast cancers
22. PSA immunoreactivity detected in LNCaP cell medium, breast tumor cytosol, and female serum
23. Frequent detection of mutations in the 5' flanking region of the prostate-specific antigen gene in female breast cancer
24. Determination of prostate-specific antigen (PSA) in cytosol of breast tumors and human endometrium-new diagnostic approaches
25. Production of PSA by breast adenocarcinoma cells: Preliminary results
26. Prognostic value of prostate-specific antigen for women with breast cancer: A large United States cohort study
27. Immunocytochemical detection of prostate-specific antigen expression in human breast carcinoma cells
28. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D
29. The promoter and the enhancer region of the KLK3 (PSA) gene is frequently mutated in breast tumors and in breast carcinoma cell line
30. Steroid hormone regulation of prostate-specific antigen expression in breast cancer
31. Prostate-specific antigen and gross cystic disease fluid protein-15 are coexpressed in androgen receptor-positive breast tumors
32. Modulation of androgen and progesterone receptors by phytochemicals in breast cancer cell lines
33. Measurement of prostate-specific antigen in detection of benign or malignant disease in women
34. Prostate-specific antigen in serum of women with breast cancer
35. Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases
36. Diagnostic value of molecular forms of prostate-specific antigen for female breast cancer
37. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer
38. Breast cancer prognostic factors - The search goes on
39. Breast: Stage Tis, T1, and T2 tumors
40. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors
41. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines
42. Ectopic production of prostate specific antigen by a breast tumor metastatic to ovary
43. Reverse transcriptase-polymerase chain reaction for prostate- specific antigen may be a prognostic indicator in breast cancer
44. Immunofluorometric analysis of p53 protein and prostate specific antigen in breast tumors and their association with other prognostic indicators
45. Prostate-specific antigen in breast cyst fluid: Possible role of prostate-specific antigen in hormone-dependent breast cancer
46. Correlation of prostate specific antigen immunoactivity (IR-PSA) to other prognostic factors in female breast cancer
47. Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer
48. Prognostic value of plasma prostate specific antigen after megestrol acetate treatment in patients with metastatic breast carcinoma
49. Expression of prostate specific antigen (PSA) correlates with poor response to tamoxifen in recurrent breast cancer